Temporally Resolved Proteomics Identifies Nidogen-2 as a Cotarget in Pancreatic Cancer That Modulates Fibrosis and Therapy Response

Scientists undertook an unbiased temporal assessment of the matrisome of the highly metastatic KPC and poorly metastatic KPflC genetically engineered mouse models of pancreatic cancer using mass spectrometry proteomics.